Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
1.465
+0.045 (3.17%)
At close: Jul 8, 2025, 4:00 PM
1.500
+0.035 (2.39%)
After-hours: Jul 8, 2025, 5:48 PM EDT
Erasca Market Cap
Erasca has a market cap or net worth of $415.02 million as of July 8, 2025. Its market cap has decreased by -25.36% in one year.
Market Cap
415.02M
Enterprise Value
53.33M
1-Year Change
-25.36%
Ranking
Category
Stock Price
$1.47
Market Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has decreased from $1.86B to $415.02M, a decrease of -77.67%. That is a compound annual growth rate of -31.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2025 | 402.27M | -43.31% |
| Dec 31, 2024 | 709.65M | 121.27% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.32B |
| Johnson & Johnson | 375.54B |
| AbbVie | 335.23B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 275.77B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.09B |
| AstraZeneca | 218.65B |